Traws Pharma
TRAW
TRAW
30 hedge funds and large institutions have $2.36M invested in Traws Pharma in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $3.61M → $2.36M (-$1.25M)
Holders
30
Holding in Top 10
–
Calls
$525K
Puts
–
Top Buyers
| 1 | +$79K | |
| 2 | +$49.2K | |
| 3 | +$37.5K | |
| 4 |
Jane Street
New York
|
+$20K |
| 5 |
SG
StoneX Group
New York
|
+$19.8K |
Top Sellers
| 1 | -$229K | |
| 2 | -$117K | |
| 3 | -$41K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$35K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$12K |